Scorpius Holdings, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
Scorpius Holdings, Inc. announced the immediate resignation of three board members, including the chairs of the Audit, Compensation, and Nominating committees.
OTC.Pink
Scorpius Holdings, Inc. completed the foreclosure sale of substantially all its non-cash assets, including its CDMO and R&D operations, to partially settle $30.2 million in secured debt.
OTC.Pink
Scorpius Holdings, Inc. has issued four non-convertible secured promissory notes totaling $239,539.77 to an institutional investor, bearing 5.0% interest and a 15% premium on repayment.
OTC.Pink
Scorpius Holdings, Inc. has extended the maturity date of a $2.25 million convertible promissory note with a related party to March 1, 2026.
OTC.Pink
Scorpius Holdings, Inc. has issued three non-convertible secured promissory notes totaling $797,020 to an institutional investor, 3i, L.P., with a 5.0% interest rate and a 15% premium on repayment.
OTC.Pink
Scorpius Holdings, Inc. has issued a $122,000 non-convertible secured promissory note to 3i, L.P. with a 5.0% annual interest rate and a maturity date of May 20, 2026.
OTC.Pink
Scorpius Holdings, Inc. has issued four non-convertible secured promissory notes totaling $1,358,176 to an institutional investor, 3i, L.P., with a 5.0% interest rate and a 15% premium on repayment.
OTC.Pink
Scorpius Holdings, Inc. received a notice of public disposition, signaling an imminent sale of its pledged assets due to over $26 million in defaults on secured notes.
OTC.Pink
Scorpius Holdings, Inc. announced the appointment of Kit Foo Chye, an experienced corporate finance professional, to its Board of Directors.
OTC.Pink
Scorpius Holdings, Inc. issued a $128,000 non-convertible promissory note to an institutional investor, accruing 5.0% interest and maturing by October 31, 2025.
OTC.Pink
Scorpius Holdings, Inc. has issued a $471,000 non-convertible promissory note to 3i, L.P., bearing 5.0% annual interest and maturing by October 31, 2025.
OTC.Pink
Scorpius Holdings, Inc. received a notice of default and acceleration for approximately $15 million in senior secured convertible notes due to multiple breaches, including payment failures and delisting.
OTC.Pink
Scorpius Holdings, Inc. issued a $500,000 non-convertible promissory note to an institutional investor, accruing 5.0% interest and maturing by October 31, 2025.
OTC.Pink
Scorpius Holdings, Inc. has issued a $490,000 non-convertible promissory note to 3i, L.P., maturing by September 30, 2025, with a 5.0% interest rate and a 5% repayment premium.
OTC.Pink
Scorpius Holdings, Inc. has amended its senior secured convertible note, introducing a lower conversion price tied to market performance and removing shareholder approval requirements, while also securing a new $485,000 non-convertible promissory note.
OTC.Pink
Scorpius Holdings, Inc. has issued a $425,000 non-convertible promissory note to 3i, L.P., bearing 5.0% interest and maturing by August 31, 2025, with a 5% principal premium on repayment.
OTC.Pink
Scorpius Holdings, Inc. has issued a $130,000 non-convertible promissory note to 3i, L.P. with a 5.0% interest rate, maturing by July 31, 2025, or upon certain corporate events or defaults.
OTC.Pink
Scorpius Holdings, Inc. reported the immediate resignation of Tan Sze Thuan from its Board of Directors, with no stated disagreements regarding company operations or policies.
OTC.Pink
Scorpius Holdings, Inc. announced the issuance of a $535,000 non-convertible promissory note to an institutional investor, bearing 5% interest and maturing by July 31, 2025, or earlier upon a corporate event or default.
OTC.Pink
Scorpius Holdings, Inc. has entered into a material agreement by issuing a $450,000 non-convertible promissory note to an institutional investor, with Jeff Wolf, CEO, providing a personal guarantee.
OTC.Pink
Scorpius Holdings, Inc. reports an updated share count after completing a private placement offering in May 2025.
OTC.Pink
Scorpius Holdings amends its senior secured convertible note and common stock purchase warrants with 3i, LP, reducing the conversion and exercise prices to $0.06.
OTC.Pink
Scorpius Holdings, Inc. will be delisted from the NYSE American after deciding not to appeal the decision, and a director, John Prendergast, Ph.D., has resigned effective immediately.
OTC.Pink
Scorpius Holdings reports its 2024 financial results, highlighting strategic cost reductions and operational streamlining in response to a challenging biotech funding environment.
OTC.Pink
Scorpius Holdings received notices from NYSE Regulation regarding non-compliance with listing standards due to a late annual report filing and a low stock price, potentially leading to delisting.
OTC.Pink
Scorpius Holdings, Inc. has entered into a financing agreement by issuing a $450,000 non-convertible promissory note to an institutional investor.
OTC.Pink
Scorpius Holdings, Inc. received a notice of lease termination for its principal manufacturing space in San Antonio, Texas, effective immediately on March 24, 2025.
OTC.Pink
Scorpius Holdings, Inc. modifies employment agreements with CEO Jeffrey Wolf and CFO William Ostrander, addressing remote work arrangements and extending Ostrander's contract with enhanced severance terms.
OTC.Pink
Scorpius Holdings, Inc. assigns its former principal office lease and amends an asset purchase agreement, eliminating a future payment in exchange for an immediate cash infusion.
OTC.Pink
Scorpius Holdings, Inc. appoints Tan Sze Thuan to its Board of Directors, increasing the board size to five members.